ESC Professional Premium Access

Epidemiology and management of patients with pulmonary arterial hypertension associated with congenital heart disease: data from the hellenic pulmonary hypertension registry (HOPE)

Congress Presentation

About the speakers

Doctor Alexandra Arvanitaki

AHEPA University General Hospital, Thessaloniki (Greece)
1 presentation
0 follower

Mr Ioannis Farmakis

Center for Thrombosis and Hemostasis, Mainz (Germany)
1 presentation
0 follower

7 more presentations in this session

Effect of a short course of parenteral treprostinil therapy on right heart structure and function in pulmonary arterial hypertension

Speaker: Doctor C. Vizza (Rome, IT)

Thumbnail

Triple therapy for incident pulmonary arterial hypertension in Finland between 2008 and 2020. A descriptive real-world FINPAH cohort study

Speaker: Doctor M. Pentikainen (Helsinki, FI)

Thumbnail

Macitentan tadalafil Fixed Dose Combination (FDC) in treatment-naive and prior monotherapy patients with Pulmonary Arterial Hypertension (PAH): insights from A DUE

Speaker: Professor P. Jansa (Prague, CZ)

Thumbnail

The effect of sildenafil on maternal mortality in pulmonary arterial hypertension associated with congenital heart disease

Speaker: Doctor N. Nahdi (Yogyakarta, ID)

Thumbnail

Efficacy comparison of prostacyclin analogue and prostacyclin receptor agonist as third line treatment for pulmonary arterial hypertension

Speaker: Doctor G. martini (Bologna, IT)

Thumbnail

Access the full session

Current treatment of pulmonary hypertension: it is all about vasodilators

Speakers: Doctor A. Arvanitaki, Mr I. Farmakis, Doctor C. Vizza, Doctor M. Pentikainen, Professor P. Jansa...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations